Sunekos Performa

Sunekos Performa is the reformulated and upgraded version of Sunekos 200.
It represents a significant evolution of Sunekos 200 in terms of its performance,
effectiveness and even faster results.

What is Sunekos Performa?

Sunekos Performa is an advanced version of Sunekos, which is extremely popular as an injectable treatment for the eye area. It is a new formulation developed by the company that manufactures Sunekos to serve as its successor.

Unlike conventional hyaluronic acid injections, Sunekos Performa is gaining attention as a ”skin-nurturing injection” that activates the skin’s natural regenerative functions to promote rejuvenation through a more natural process.

Its formula consists of a special blend of non-crosslinked hyaluronic acid and six types of amino acids in a specific ratio.

Key features:

Promotes the regeneration and functional improvement of the extracellular matrix (ECM)
Rebuilds the structure of the dermis and encourages the skin itself to regenerate
Highly effective in improving firmness, elasticity, and radiance
Particularly effective for rejuvenating the eye area

Increased Ingredient Amount

Amino acid content: increased by 28%, from 100 mg to 128 mg
Low-molecular-weight hyaluronic acid: increased from 30 mg to 35 mg

Reduces the hyaluronic acid degradation reaction by 40%
Further boosts the production of collagen and elastin

Thanks to the increased ingredient amounts and reduced degradation reaction, the effects last longer.
Through these improvements, Sunekos Performa is more effective than Sunekos and offers longer-lasting results.

Enhanced effects

Improved longevity

Sunekos® 1200

Designed to support skin quality and extracellular matrix balance through a patented combination of hyaluronic acid and amino acid.

Sunekos® 1200 (2 × 1.5 mL Vials)
Sunekos® 1200 is an injectable medical device formulated with a high concentration of hyaluronic acid combined with a specific amino acid complex. Developed by Professional Dietetics S.p.A., this formulation is designed for dermal biostimulation and structural extracellular matrix support in areas requiring enhanced tissue density.

Compared with Sunekos 200 (Performa), Sunekos 1200 contains a higher HA concentration (1200 mg per vial set) and is positioned for treatment of areas with more advanced laxity or volume loss. It is not intended as a traditional volumising dermal filler but rather as a biostimulatory injectable supporting collagen and elastin synthesis.

What Sunekos® 1200 Is Similar To
Sunekos 1200 can be regarded alongside other biostimulation injectables designed to improve dermal density and elasticity rather than provide structural filling. Compared with cross-linked hyaluronic acid fillers, it uses non-cross-linked HA combined with amino acids to support natural tissue regeneration.

In clinical discussions, queries such as “sunekos 1200 injection points” or “sunekos 1200 how to use” relate to its structured intradermal application protocol. Unlike volumising fillers, its effect is based on matrix stimulation rather than mechanical lift. This comparison is provided for clinical orientation only and does not imply interchangeability.

Treatment Areas / Indications
According to manufacturer documentation, Sunekos 1200 is indicated for dermal biostimulation and treatment of moderate to advanced skin laxity.

Treatment areas may include:
Face • Neck • Décolletage • Areas of structural dermal thinning
→ Sunekos 1200 is intended for intradermal or deep dermal placement depending on indication and practitioner assessment.

Sunekos Performa